Planta Medica · 2013 · 22 citations · 15 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryPlant BiochemistryStructure-activity RelationshipsIn Vitro PharmacologyMedicinal PlantsStructure-activity Relationship AnalysisBioactive Plant CompoundsFlavonoid GlycosidesHypoxia-reoxygenation InjuryPharmacological ScreeningPlant Extract InhibitorsReoxygenation Effects
Six new 9,19-cycloartane triterpene glycosides, heracleifolinosides A-F (1-6), and one new chromone, norkhelloside (7), were isolated from the rhizome of Cimicifuga heracleifolia, together with 15 known compounds (8-22). The structures of the new compounds were elucidated by means of spectroscopic methods including 2D NMR and mass spectrometry. The extracts of C. heracleifolia and all the isolated compounds were tested for activities against hypoxia and reoxygenation injury in human umbilical vein endothelial cells. Heracleifolinoside B (2) is effectively resistant to hypoxia and reoxygenation-induced human umbilical vein endothelial cell injury, with cell viabilities of 61.95 ± 2.04 %, 77.04 ± 4.44 %, and 83.65 ± 3.29 % at concentrations of 1, 10, and 100 µM, respectively.
15
James A. Compton, Alastair Culham, Stephen L. Jury · Taxon · 1998 · 128 citations · Full text
Triterpene Glycosides from <i>Cimicifuga racemosa</i>
Yu Shao, Amanda Harris, Mingfu Wang et al. · Journal of Natural Products · 2000 · 96 citations
Life Sciences, Biochemistry, Biology +14
Shao‐Nong Chen, Wenkui Li, Daniel S. Fabricant et al. · Journal of Natural Products · 2002 · 95 citations
Life Sciences, Botany, Plant Biology +12
Chromones from the tubers of Eranthis cilicica and their antioxidant activity
Minpei Kuroda, Singo Uchida, Kazuki Watanabe et al. · Phytochemistry · 2009 · 84 citations